Engineering epidermal growth factor for enhanced mitogenic potency

Nature Biotechnology

Volumn 14, Issue 13, 1996, Pages 1696-1699

  Reddy, Cartikeya C ^a,b   Niyog, Salil K ^c   Wells, Alan ^d   Wiley, H Steven ^e   Lauffenburger, Douglas A ^d  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c OAK RIDGE NATIONAL LABORATORY   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CELL DIVISION; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; MICE; MITOGENS; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMALIA;

EID: 0029852598     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1296-1696     Document Type: Article

References (14)

1. Sporn, M. and Roberts, A.B. (eds.). 1990. Peptide growth factors and their receptors. Springer-Verlag, Berlin.
2. Pimental, E. 1990. Handbook of growth factors, volume II: peptide growth factors. CRC Press, Boca Raton, FL.
3. Wolfe, R.A. 1993. Media for cell culture, pp. 142-156 in Biotechnology, volume 3: bioprocessing. Stephanopolous, G. (ed.). VCH Publishers Inc., New York, NY.
4. Meyer-Ingold, W. 1993. Wound therapy: growth factors as agents to promote healing. Trends Biotechnol. 11:387-392.
5. Langer, R. and Vacanti, J.P. 1993. Tissue engineering. Science 260:920-926.
6. Krueger, G.G., Morgan, J.R., Jorgensen, CM., Schmidt, L., Li, H.L., Kwan, M.K., et al. 1994. Genetically modified skin to treat disease: potential and limitations. J. Invest. Dermatol. 103:76S-84S.
7. Wiley, H.S. 1992. Receptors: topology, dynamics, and regulation, pp. 113-142 in Membrane dynamics and signaling. JAI Press Inc., Greenwich, CT.
8. Moody, P.C.E. and Wilkinson, A. 1990. Protein engineering. Oxford University Press, New York.
9. Reddy, C.C., Wells, A., and Lauffenburger, D.A. 1994. Proliferative response of fibroblasts expressing internalization-deficient epidermal growth factor (EGF) receptors is altered via differential EGF depletion effect. Biotechnol. Prog. 10:377-384.
10. Reddy, C.C., Wells, A., and Lauffenburger, D.A. 1996. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor a. J. Cell. Physiol. 166:512-522.
11. Tadaki, D.K. and Niyogi, S.K. 1993. The functional importance of hydropho-bicity of the tyrosine at position 13 of human epidermal growth factor in receptor binding. J. Biol. Chem. 268:10114-10119.
12. French, A.R., Tadaki, D.K., Niyogi, S.K., and Lauffenburger, D.A. 1995. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J. Biol. Chem. 270:4334-4340.
13. Chang, D.Z., Wu, Z., and Ciardelli, T.L. 1996. A point mutation in interleukin-2 that alters ligand internalization. J. Biol. Chem. 271:13349-13355.
14. Chen, P., Gupta, K., and Wells, A. 1994. Cell movement elicited by the epidermal growth factor requires kinase and autophosphorylation but is separable from mitogenesis. J. Cell. Biol. 124:547-555.